Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy

Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy

Immunotherapy, particularly immune checkpoint blockade and chimeric antigen receptor (CAR)-T cells, holds a great promise against cancer. These treatments have markedly improved survival in solid as well as in hematologic tumors previously considered incurable. However, durable responses occur in a...

Full description

Bibliographic Details
Main Authors:	Laura Bracci, Alessandra Fragale, Lucia Gabriele, Federica Moschella
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Immunology
Subjects:	immunotherapy chimeric antigen receptor T (CAR-T) immune-checkpoints multi-parametric analysis multi-omics deep immunophenotyping
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.582744/full

Similar Items

Barriers to overcoming immunotherapy resistance in glioblastoma
by: Julia S. Gillette, et al.
Published: (2023-05-01)

Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
by: Yan-Ruide Li, et al.
Published: (2024-01-01)

Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
by: Diana Gumber, et al.
Published: (2022-03-01)

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
by: Peng Zhang, et al.
Published: (2022-07-01)

Newest Approaches in Immunotherapy for Non-Hodgkin’s Lymphoma
by: Emily C. Ayers, et al.
Published: (2018-12-01)

CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
by: Ler Yie Chan, et al.
Published: (2022-03-01)

Immunotherapy of glioblastoma: Recent advances and future prospects
by: Boyang Yuan, et al.
Published: (2022-11-01)

Immunological and translational aspects of NK cell-based anti-tumor immunotherapies
by: Maxim Shevtsov, et al.
Published: (2016-11-01)

CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
by: Kaveh Hadiloo, et al.
Published: (2023-05-01)

CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors
by: Anna C. Filley, et al.
Published: (2018-10-01)

The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
by: Dongfang Liu, et al.
Published: (2020-08-01)

Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond
by: Zhaokai Zhou, et al.
Published: (2024-06-01)

Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism
by: Quanjun Yang, et al.
Published: (2022-12-01)

Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective
by: Chiara Donini, et al.
Published: (2021-03-01)

Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients
by: Cihan Taştan, et al.
Published: (2020-11-01)

CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
by: Li-Na Zhang, et al.
Published: (2018-03-01)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
by: Siyao Liu, et al.
Published: (2022-12-01)

The Notch signaling pathway: a potential target for cancer immunotherapy
by: Xinxin Li, et al.
Published: (2023-05-01)

CAR-T immunotherapy - recent advances and current challenges in cancer treatment: a review.
by: Joanna Ronowicz-Pilarczyk
Published: (2024-06-01)

Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
by: Ewelina Grywalska, et al.
Published: (2020-04-01)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
by: Kevin Pan, et al.
Published: (2022-03-01)

Immunotherapy in Pediatric Solid Tumors
by: Jung Yoon Choi
Published: (2020-04-01)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
by: Gyuhee Seong, et al.
Published: (2023-03-01)

CAR-macrophage: Breaking new ground in cellular immunotherapy
by: Ting Huang, et al.
Published: (2024-10-01)

Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
by: Jessica Waibl Polania, et al.
Published: (2021-11-01)

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
by: Maria Giraudo, et al.
Published: (2024-03-01)

Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression
by: Wei Jiang, et al.
Published: (2023-11-01)

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future
by: Samer A. Srour, et al.
Published: (2023-01-01)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
by: Piotr Celichowski, et al.
Published: (2023-03-01)

CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
by: Elisabetta Cribioli, et al.
Published: (2022-08-01)

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
by: Zakaria Grada, et al.
Published: (2013-01-01)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01)

PLAP -CAR Tcells mediate high specific cytotoxicity against colon cancer cells
by: Xin Li, et al.
Published: (2020-06-01)

Opportunities for CAR-T Cell Immunotherapy in HIV Cure
by: Gerard Campos-Gonzalez, et al.
Published: (2023-03-01)

Study of the suppression of a tumor growth expressing a carcinoembryonic antigen with a new high-tech drug carplasmin (CAR-T therapy) in Balb/c nude mice
by: V. K. Bozhenko, et al.
Published: (2023-04-01)

Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive Immunotherapy
by: Anne-Sophie Gautron, et al.
Published: (2017-12-01)

Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy
by: Susannah C. Shissler, et al.
Published: (2017-11-01)

Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer
by: Ernesto Lopez, et al.
Published: (2023-12-01)

Nano-immunotherapy for lung cancer
by: Yuting Lu, et al.
Published: (2023-03-01)

CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond
by: Jialin Lu, et al.
Published: (2024-08-01)